関連する実験動画
Updated: Feb 14, 2026

06:44
Demonstration of Cutaneous Allodynia in Association with Chronic Pelvic Pain
Published on: June 23, 2009
20.4K
皮膚結核は慢性皮膚疾患として表れている
Olivia Spina1, Henry Fraimow1,2, Justin Green1,3
1Cooper Medical School of Rowan University, Camden, New Jersey, USA, rowan.edu.
Case reports in dermatological medicine
|February 13, 2026
まとめ
皮膚結核 (CTB) の診断は,さまざまなプレゼンテーションのために困難である可能性があります. インターフェロン・ガンマ放出アッセイ (IGRA) は,この皮膚結核のパウシバシラー型を診断するのに役立ちます.
科学分野:
- 皮膚科 皮膚科について
- 感染症 感染症は感染症です.
- 微生物学 微生物学とは
背景:
- 皮膚結核 (Cutaneous tuberculosis,CTB) は,肺の外結核の珍しい形態である.
- Tuberculosis verrucosa cutis (TBVC) は,パウシバキラー性であり,他の皮膚疾患に類似しているため,診断上の課題を提示しています.
研究 の 目的:
- 皮膚結核の困難な症例において,インターフェロン・ガンマ放出アッセイ (IGRAs) の診断的有用性を強調する.
- TBVCの管理上の困難と治療戦略について議論する.
主な方法:
- 誤診された皮膚病変の10年間の歴史を持つ73歳の女性の症例報告.
- 伝統的な方法 (ステイン,培養,PCR) が陰性であった場合,QuantiFERON-TB ゴールドテストを使用しました.
- 標準的抗結核療法 (HRZE) に対する文書化された副作用.
主要な成果:
- 陽性のQuantiFERON-TB Gold検査は,マイナスの微生物学的検査にもかかわらず,TBVCの診断を確認しました.
- 患者はピラジナミドとリファミンピンの副作用を経験しました.
- 代替治療のレジミンは,許容性と臨床解像度の改善につながった.
結論:
- IGRAは,パウシバチラー性皮膚結核の診断に役立つ貴重なツールです.
- TBVCの管理には,診断上の落とし穴に注意を払い,薬剤の副作用を慎重に検討する必要があります.
- 個別化された治療アプローチは,TBVCの効果的な管理に不可欠です.
関連する概念動画
Chronic Bowel Disorders: Introduction
816
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
816
Intrinsically Disordered Proteins
19.6K
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.6K
Pulmonary Tuberculosis I
1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Pulmonary Tuberculosis II
1.6K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.6K
Pulmonary Tuberculosis V
651
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
651
Pulmonary Tuberculosis III
1.1K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.1K

